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Abstract Degenerative lumbar stenosis is a common
source of pain and disability in the elderly. It presents clini-
cally with a variety of symptoms, though neurogenic
claudication is the hallmark. There is a multifactorial path-
ogenesis to lumbar stenosis and its symptoms, and thus, there
are multiple management approaches available. Epidural
steroid injections (ESIs) are a popular choice in manage-
ment, however, the literature is vague in deﬁnitive support of
their use, and providers that utilize injections can use variable
techniques to access the spinal canal in order to deposit the
steroid at the appropriate site. This article will review
degenerative lumbar stenosis in general and focus on the use
of ESIs to better deﬁne their role in this management process.
In addition, the evidence to discern the optimal injection
route will be presented.
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Introduction
Degenerative lumbar spinal stenosis (LSS) is a common
source of pain and disability in the elderly population.
Neurogenic claudication is the hallmark symptom of LSS,
classically described as buttock and bilateral leg pain initi-
ated by walking, prolonged standing, and walking
downhill (relative lumbar extension). It is typically relieved
by sitting, bending forward, or pushing a grocery cart. This
is contrasted with vascular claudication where pain is
relieved solely by rest(not having to sit or bend forward), and
walking uphill is worse.
Neurogenic claudication typically results from stenosis of
the central spinal canal. LSS is a result of the degenerative
spine cascade, and thus, narrowing not only can affect the
central spinal canal, but also the lateral recesses and inter-
vertebral foramina [1]. Due to the variable regions affected,
patients with LSS can present with unilateral or bilateral, and
monoradicular or polyradicular symptoms. They can also
present with frank radiculopathy, i.e., weakness, sensation
loss, and reﬂex loss in a myotomal and dermatonal distribu-
tion. Back pain is also a common complaint of patients with
LSS. The quality of this axial symptom is consistent with
osteoarthritis of the lumbar spine (stiffness with a dull,
aching pain). Patients tend to default to a stooped-forward
posture to alleviate pain by widening the spinal canal and
decreasing the forces on the zygaphophyseal joints.
The natural history of LSS is not entirely known. How-
ever, it is known that rapid neurological progression is rare.
Despite methodological limitations, most studies of nonop-
erative therapy for lumbar stenosis report 15–45%
improvement, 15–30% worsen, and the rest remain symp-
tomatically about the same [2–5]. In a study with 8–10-year
follow-up comparing surgical to nonoperative therapy, early
outcomes at 1 and 4 years favored surgical management;
however, after 8–10 years, low back pain outcome, pre-
dominant symptom (either back or leg pain) improvement,
and satisfaction with their current status were similar. Leg
pain relief, though, still favored those treated surgically [6].
Multifactorial pathogenesis
We know that the pathogenesis of LSS is multifactorial. If
narrowing and compression were the sole pathologic
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cea. There are vascular, biochemical, and biomechanical
factors that contribute to the symptoms of LSS, and thus,
need to be considered as much as the physical compression.
The vascular factors include venous engorgement and
arterial insufﬁciency of the radicular blood supply, which
can lead to an ischemic neuritis.
In the venous engorgement theory, spinal veins dilate
during ambulation in stenotic patients, thus, blood ﬂow
stagnates and intrathecal pressures rise, which cause a
microcirculatory neuroischemic insult and subsequently,
claudication symptoms [7, 8].
Arterial insufﬁciency is another proposed source of the
claudication symptoms of LSS. With lower limb exercise,
including ambulation, the lumbar radicular arterioles dilate
to provide nourishment to the spinal nerve roots. In patients
with stenosis, however, this arterial dilation may be
defective [9].
The inﬂammatory cascade is another component of this
multifactorial pathogenesis. Over the years, multiple
inﬂammatory mediators have been implicated in the
pathogenesis of radicular symptoms due to disk hernia-
tions, including phospholypase A2, cytokines, nitric
oxide, lactate, and immune cells [10]. The antigenic
nucleus pulposis leaks out of its immunoprotected envi-
ronment and induces a local immune response. These
inﬂammatory mediators may enhance the excitability of
the dorsal root ganglion under a state of chronic com-
pression from stenosis. However, the true role of immune-
mediated inﬂammation has not yet been elucidated in the
setting of spinal stenosis. Theoretically, in LSS,
mechanical compression of a nerve root may be a ‘‘pri-
mer’’ for a subsequent inﬂammatory response, which
ultimately causes the radicular symptoms. This may be an
explanation for the patient with chronic LSS to have
periodic acute ﬂares of symptoms. A chronically inﬂamed
nerve root, with increased mechanical sensitivity, can
become perturbed by a new inﬂammatory precipitator,
vascular changes, or degenerative instability [9].
Patients with LSS have disk and zygapophyseal joint
degeneration, which can lead to a degenerative spondylo-
listhesis. The resultant mechanical instability can cause a
‘‘dynamic radiculopathy’’ by imposing a stretch on the
nerve root as it passes through the unstable level. This
instability may result in further vascular and inﬂammatory
changes, which contribute to the multifactorial pathogensis
of symptoms.
Treatment
Treatment for LSS includes conservative (activity modi-
ﬁcation, assistive devices for ambulation, medications,
and exercise) and interventional (ESIs and surgery)
approaches. Treatment decisions should be driven in part
by patient preference. Some patients would never con-
sider interventional treatments unless all conservative
options were exhausted. Others with severe and disabling
symptoms may opt for more aggressive management
earlier. As clinicians, we need to inform our patients of
the possible treatments, and guide them appropriately
(See Table 1).
Surgical intervention has variable outcomes, though
most studies describe good to excellent overall results [2, 6,
11]. However, conservative treatment is a viable initial
option for many patients. Except in severe cases, there is no
evidence that neurologic deterioration occurs over time,
and delaying surgery in those choosing initial conservative
management does not adversely affect the post-operative
outcome [12]. Consider nonoperative management as a
means of managing ongoing symptoms and functional
deﬁcits as opposed to substantially altering the natural
history of LSS.
Epidural steroid injections are frequently used in a
nonoperative management regime (Figs. 1 and 2). They
should be used as an adjunct to a comprehensive reha-
bilitation program and not used in isolation. The pain
relief obtained with injections can facilitate the patient’s
tolerance of a rehabilitation program, which is the main
component of treatment used to decrease patient
disability.
Unfortunately, there is no clear evidence to guide us on
when to initiate a trial of epidural steroids, nor to assist in
determining the frequency and duration of treatment. Lit-
erature does support their use for predominantly radicular
symptoms, especially acutely, and less for axial symptoms.
The ‘‘series of three’’ is out of fashion now that ﬂuoro-
scopic guidance and more speciﬁc routes of administration
are utilized routinely. If one well-placed injection is not
effective, then it is unlikely that a second or third admin-
istered in the same location will be. However, potentially a
different route of administration could be utilized for a
second injection.
Table 1 Management of degenerative lumbar stenosis
Conservative
1. Activity modiﬁcation (limit extension-based activity)
2. Assistive device for ambulation (walker)
3. Medications (Tylenol, NSAIDs, neuromodulating agents, and low
dose opiates)
4. Physical therapy and exercise
Interventional
1. Epidural corticosteroid injections
2. Surgery
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for corticosteroids. These include the inhibition of nerve
root edema with improved microcirculation and reduced
ischemia, inhibition of prostaglandin synthesis, and also
the noninﬂammatory action of direct inhibition of C-ﬁber
neuronal membrane excitation [13, 14].
Technique
There are three injection approaches to access the lumbar
epidural space: the interlaminar, caudal, and transforminal
techniques. The interlaminar and caudal approaches his-
torically were performed without ﬂuoroscopic guidance;
however, there is a 30–40% miss rate, even in experienced
hands, without ﬂuoroscopic guidance, thus, ﬂuoroscopy is
recommended for all approaches [15, 16].
Interlaminar approach
This procedure can be performanced at any interlaminar level
in the lumbar spine, though most commonly is performed at
L4–5. The injectant typically stays in the posterior epidural
space and can travel a level or two caudad or cephalad,
dependingonthevolume injected.Thus,anL3-4interlaminar
ESI could be considered in the patient with diffuse, nonlo-
calizing bilateral symptoms of neurogenic claudication with
notable L3-4 central stenosis on MRI. However, to access the
anterior epidural space, bilateral L4-5 transforaminal
approaches may be considered in this same scenario (Fig. 3).
Caudal approach
The entry point for this approach is the sacral hiatus.
Typically, a larger volume of injectant is administered to
Fig. 1 An 64-year-old female
with symptoms of bilateral
lower limb neurogenic
claudication with symptomatic
improvement with a caudal
epidural steroid injection. An
interlaminar approach could
have been considered
appropriate, as well. (a) Sagittal
view of a T2-weighted MRI of
the lumbar spine. Note the grade
I spondylolisthesis of L4 on L5
with severe central canal
stenosis. (b) and (c) Axial views
of a T2-weighted MRI through
L4–5. Note the diffuse disc
bulge in (b) and the marked
ligamentum ﬂavum hypertophy
in (c), both contributing to the
severe central stenosis. (d) The
L5-S1 level showing no
evidence of stenosis
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majority of injectant can reach the L5-S1 and L4-5 levels,
thus treating higher level pathology via a caudal approach
is not recommended. This approach is used for L4-5 and
L5-S1 pathology when symptoms are more diffuse (not
monoradicular-when a transforaminal approach would be
desirable), or if there is a concern of epidural scarring in a
post-operative patient (when performing an interlaminar
approach would risk dural puncture). Thus, a caudal ESI
could be considered in the patient with nonlocalizing,
bilateral symptoms of neurogenic claudication with MRI
conﬁrmed L5-S1 central stenosis. Both an interlaminar and
caudal route are better for more diffuse symptoms, or when
there is multilevel pathology contributing to the patient’s
symptoms (Fig. 4).
Transforaminal approach
This approach requires ﬂuoroscopic guidance and is the
most selective of the three. The transforaminal approach
allows access to the ventral epidural space, where the
disk lies, and thus, is thought to be most effective for a
monoradiculopathy due to disk herniation. Thus, a
patient with right L5 radicular symptoms and MRI
conﬁrmed L4-5 central or lateral recess stenosis, may
most beneﬁt from a right L5-S1 transforaminal ESI
(Fig. 5).
Outcomes
There are limited studies evaluating the efﬁcacy of ESIs
for degenerative lumbar stenosis, as the majority of
injection outcome studies are evaluating lumbosacral
radiculopathy secondary to disk herniation. There are no
studies comparing efﬁcacy of injection techniques in
patient with LSS.
Of the four studies evaluating the efﬁcacy of non-
ﬂuoroscopically guided lumbar ESIs for LSS, all
showed a short-term beneﬁt ranging from 1 week to 2
months of relief, and only one [17] demonstrated a
longer term beneﬁt with up to 10 months of relief [17–
20]. The Ciocon [17] and Hoogmartens [19]s t u d i e s
used a caudal approach, where the Fukusaki [18]a n d
Rosen [20] studies used the interlaminar approach. The
more recent studies used ﬂuoroscopic guidance, but also
demonstrated variable results [21–24]. All demonstrated
some short-term beneﬁt; however, the Botwin study
[22], the only prospective evaluation, showed a sub-
stantial long-term beneﬁt as well. This study evaluated
34 patients with unilateral radicular symptoms
Fig. 2 An 84-year-old male with low back pain and right L4
radicular symptoms to the ankle worsened with walking with
symptomatic improvement with a right L4-5 transforaminal epidural
steroid injection. (a) Right sagittal view of a T2-weighted MRI of the
lumbar spine. Note the multilevel degenerative changes and the
foraminal stenosis at L4-5 related to disc bulge and facet hypertrophy.
(b) Axial view of a T2-weighted MRI through L4-5. Note severe
central stenosis on imaging, though symptomatically, he described
right L4 radicular symptoms and thus a transforaminal route was
chosen
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raminal ESIs. A mean of 1.9 injections per patient was
performed. Subjects were evaluated at 2 months and
1 year with a visual analog scale, Roland 5-point scale,
standing/walking tolerance scale, and patient satisfac-
tion scale. All outcome measures demonstrated a
statistically signiﬁcant improvement at 2 and 12 months
when compared to the pre-injection baseline. The
patient satisfaction scale revealed that 62% of patients
at 2 months and 64% of patients at 12 months felt
somewhat or completely better.
Conclusion
There is limited research evaluating the appropriate use of
lumbar ESIs speciﬁcally to treat LSS, and thus, speciﬁc
conclusions cannot be drawn. There is no information to
conclude which injection technique is most efﬁcacious. For
now, treatment decisions can be adapted from the literature
on injections for symptomatic disc herniation and radicu-
lopathy. These studies conﬁrm that ESIs are best used for
acute radicular pain, and that the transforaminal approach
can target the primary site of pathology better than an
Fig. 3 Fluoroscopic images of
an L3-4 interlaminar approach.
(a) AP view, pre-contrast, (b)
Lateral view, pre-contrast, and
(c) Lateral view, post-contrast
36 Curr Rev Musculoskelet Med (2008) 1:32–38interlaminar approach and thus is probably more efﬁca-
cious [25–27].
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